Back
ESC Premium Access

Zilver PTX post-market surveillance study of paclitaxel-eluting stents for treating femoropopliteal artery disease in Japan: 24-month results

Session: Poster session 1 - Peripheral interventions
Topic: Percutaneous / endovascular treatment
Speaker: Doctor H. Yokoi (Fukuoka, JP)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Hiroyoshi Yokoi

Fukuoka Sanno Hospital, Fukuoka (Japan)
0 follower

19 more presentations in this session

The difference of clinical factors on patency after endovascular therapy for femoropopliteal lesions between stent implantation and balloon angioplasty

Speaker: Doctor S. Hiramori (Kitakyushu, JP)

Access
Abstract
Slides
Like
Thumbnail

Clinical outcomes of endovascular therapy for patients with critical hand ischemia

Speaker: Doctor Y. Tomoi (Kitakyushu, JP)

Access
Abstract
Slides
Like
Thumbnail

Revascularization by endovascular treatment restores peripheral sensory disturbance in patients with critical limb ischemia

Speaker: Doctor E. Shibahashi (Tokyo, JP)

Access
Abstract
Like
Thumbnail

Optimal antithrombotic therapy for patient with an indication for long term oral anticoagulation undergoing femoropopliteal stenting.

Speaker: Doctor K. Makino (Yokohama, JP)

Access
Abstract
Like
Thumbnail

A comparison of combined balloon expandable and self-expandable nitinol stent vs double self-expandable nitinol stents for long aorto-iliac disease.

Speaker: Doctor Y. Takeji (Kanazawa, JP)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 1 - Peripheral interventions

Speakers: Doctor H. Yokoi, Doctor S. Hiramori, Doctor Y. Tomoi, Doctor E. Shibahashi, Doctor K. Makino...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources